Art

J-GLOBAL ID：201702227793375078   Reference number：17A0378671

Vildagliptin reduces plasma stromal cell-derived factor-1α in patients with type 2 diabetes compared with glimepiride

ビルダグリプチンはグリメピリドと比較して2型糖尿病患者の血漿ストロマ細胞由来因子-1αを減少させる

Author (7)： Park Kyeong Seon (Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea) ,  Kwak SooHeon (Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea) ,  Cho Young Min (Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea) ,  Park Kyong Soo (Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea) ,  Jang Hak C (Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea) ,  Kim Seong Yeon (Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea) ,  Jung Hye Seung (Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea)
Material： Journal of Diabetes Investigation (Web)  (JDI (Web))
Volume： 8  Issue： 2  Page： 218-226  Publication year： 2017 
JST Material Number： U0507A  ISSN： 2040-1124  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *SDF-1 alpha ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0378671&from=J-GLOBAL&jstjournalNo=U0507A") }}

Author keywords (3)： Cardiovascular risk ,  Stromal cell-derived factor-1α ,  Vildagliptin

JST classification (3)： Treatment for metabolic diseases,nutritional diseases.  (GD05030F) ,  Clinical application of drugs acting on carbohydrate metabolism  (GW13030B) ,  Basic research of drugs acting on lipid metabolism  (GW13040M)

Substance index (2)： Glimepiride ,  Vildagliptin

Reference (42)：

• Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 2010; 33: 1389-1394.
• Jung HS. Clinical implications of glucose variability: chronic complications of diabetes. Endocrinol Metab (Seoul) 2015; 30: 167-174.
• Ross R. Atherosclerosis-an inflammatory disease. New Engl J Med 1999; 340: 115-126.
• Drucker DJ. Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action. Diabetes Care 2007; 30: 1335-1343.
• Monnier L, Colette C, Comenducci A, et al. Add-on therapies to metformin in type 2 diabetes: what modulates the respective decrements in postprandial and basal glucose? Diabetes Technol Ther 2012; 14: 943-950.

Terms in the title (7)： ビルダグリプチン ,  グリメピリド ,  2型糖尿病 ,  患者 ,  血漿 ,  ストロマ細胞 ,  因子